AstraZeneca expiry change based on science but communication is key: experts
OTTAWA — Many immunologists and infectious disease experts are rushing to convince Canadians that extending the expiration date on some Oxford-AstraZeneca doses is a normal and scientifically sound decision.
Health Canada said Saturday it had approved adding another month to the shelf life of two lots of Oxford-AstraZeneca vaccine that were due to expire Monday.
Ontario asked the company if the change could happen to save up to 45,000 doses that were expiring, but the decision affects remaining doses from the two affected lots in every province. Fewer than 100,000 doses are left from those two lots.
Health Canada’s chief medical adviser, Dr. Supriya Sharma, said in an interview with The Canadian Press Monday that the decision was made after AstraZeneca submitted data supporting the change last week.


